PPARγ Protects Against Renal Ischemia-Reperfusion Injury Through Mir-21/Pdcd4/caspase-3 Axis

Ruizhen Huang,Cong Zou,Chiyu Zhang,Xing Wang,Xin Zou,Zhengjie Xiang,Zewei Wang,Bin Gui,Tao Lin,Honglin Hu
DOI: https://doi.org/10.2139/ssrn.4092984
2022-01-01
SSRN Electronic Journal
Abstract:Renal ischemia-reperfusion injury (RIRI) is regarded as a relatively common pathological process that causes kidney injury. Previous studies have indicated that both peroxisome proliferator-activated receptor γ (PPARγ) and microRNA-21(miR-21) exerted protective effects in renal IRI, but the relationship between them was rarely known. In the present study, we investigated the role of the PPARγ/miR-21/PDCD4 axis in IRI both in vivo and in vitro. In vitro cell hypoxia/reoxygenation (H/R) model and in vivo renal IRI model was established, and the cell viability, apoptosis, immunocytochemical analysis, western blot etc. were performed for further research. Our results showed that both PPARγ and miR-21 had protective effects on renal IRI to varying degrees, and there was an interaction between PPARγ and miR-21. PPARγ could promote the expression of miR-21, and partially protect renal IRI by reducing the level of miR-21 target protein PDCD4. Our findings underscore the potential utility of future clinical investigations whereby PPARγ activation and hence targeting the underlying miR-21/PDCD4/caspase-3 pathway which may participate in the human IRI pathogenesis.Funding: Grants from the China National Natural Science Foundation (No. 81860128) and Jiangxi Provincial Natural Science Foundation Project (No.20171BAB205016) supported the whole study, funders had no role in this works.Declaration of Interest: No conflicts of interest exit in the submission of this manuscript, and manuscript is approved by all authors for publication.Ethical Approval: The pathogen-free male C57BL/6 mice (8–10 weeks old, weighing 18~20 g) were obtained from the Laboratory Animal Center of Nanchang University (Nanchang, Jiangxi, China), and this study was assessed and approved by the Ethics Committee for Animal Experiments of the Second Affiliated Hospital of Nanchang University.
What problem does this paper attempt to address?